PULMONARY EMBOLISM (PE)
Clinical trials for PULMONARY EMBOLISM (PE) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY EMBOLISM (PE) trials appear
Sign up with your email to follow new studies for PULMONARY EMBOLISM (PE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 30-Day blood thinner regimen prevent clots after spine cancer surgery?
Disease control Not yet recruitingPeople who have spine surgery for cancer that has spread are at high risk for dangerous blood clots in the legs or lungs. Currently, blood-thinning medicine is stopped when patients leave the hospital. This trial tests whether taking apixaban (Eliquis) by mouth for 30 days after …
Matched conditions: PULMONARY EMBOLISM (PE)
Phase: PHASE4 • Sponsor: James Bayley • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New catheter aims to dissolve dangerous lung clots more precisely
Disease control Not yet recruitingThis pilot study tests a new catheter device designed to deliver clot-dissolving medication directly to blood clots in the lungs of adults with intermediate-risk pulmonary embolism. The goal is to see if the device can be used safely and as intended. All 20 participants will rece…
Matched conditions: PULMONARY EMBOLISM (PE)
Phase: NA • Sponsor: Flow Medical Solutions, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a simple CT scan replace an invasive procedure to detect dangerous heart clots?
Diagnosis Not yet recruitingThis study explores whether an additional CT scan of the heart, taken right after a standard scan for lung clots, can effectively detect blood clots in the left atrial appendage (LAA) in people with atrial fibrillation. Currently, detecting these clots requires a more involved pr…
Matched conditions: PULMONARY EMBOLISM (PE)
Phase: NA • Sponsor: Northwell Health • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC